|
Sciele Pharma and Plethora Solutions Announce Final Analysis of …
UroToday, CA - 2 hours ago There are currently no approved pharmaceutical treatments for premature ejaculation. In May 2007, Plethora signed an exclusive license agreement with Sciele … |
|
Sciele Pharma and Plethora Solutions Announce Final Analysis of …
UroToday, CA - 4 hours ago There are currently no approved pharmaceutical treatments for premature ejaculation. In May 2007, Plethora signed an exclusive license agreement with Sciele … |
|
Sciele Pharma and Plethora Solutions Announce Final Analysis of …
UroToday, CA - 6 hours ago There are currently no approved pharmaceutical treatments for premature ejaculation. In May 2007, Plethora signed an exclusive license agreement with Sciele … |
|
Sciele Pharma and Plethora Solutions Announce Final Analysis of …
UroToday, CA - 8 hours ago There are currently no approved pharmaceutical treatments for premature ejaculation. In May 2007, Plethora signed an exclusive license agreement with Sciele … |
|
Sciele Pharma and Plethora Solutions Announce Final Analysis of …
UroToday, CA - 10 hours ago There are currently no approved pharmaceutical treatments for premature ejaculation. In May 2007, Plethora signed an exclusive license agreement with Sciele … |
|
Sciele Pharma and Plethora Solutions Announce Final Analysis of …
MarketWatch - Dec 8, 2008 There are currently no approved pharmaceutical treatments for premature ejaculation. In May 2007, Plethora signed an exclusive license agreement with Sciele … |
|
Small caps round-up: Ten Alps/BT, Monitise, Plethora…
ShareCast, UK - 8 hours ago Plethora Solutions's final analysis of its European Phase III double-blind placebo controlled study of PSD502 for the treatment of premature ejaculation met … |
|
Sciele Pharma and Plethora Solutions Announce Positive Phase III …
PR-Inside.com (Pressemitteilung), Austria - Nov 9, 2008 European Phase III double-blind placebo-controlled study of PSD502 for the treatment of premature ejaculation ('PE') has met its three co-primary endpoints … |
|
PRESS DIGEST – British business press – Nov 8
Forbes, NY - 22 hours ago Shares in Plethora Solutions rose 8.5 pence to 24 pence after the company announced positive phase III trials for its treatment for premature ejaculation. … In the know: JJB Sports, Shire, Vodafone and Plethora Solutions Times Online all 2 news articles |
|
Plethora rises on premature ejaculation drug
Financial Times, UK - Nov 7, 2008 Shares in Plethora Solutions soared more than 60 per cent on Friday following successful trial data for its premature ejaculation drug. … Drug trial success for Plethora Financial Times all 2 news articles |